NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of Endeavour Group Holdings, IncNEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of Endeavour Group Holdings, Inc

Rosen Law Firm Urges Sellers of Endeavor Group Holdings, Inc. (NYSE: EDR) Stock to Contact the Firm for Information About Their Rights

NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of sellers of Endeavour Group Holdings, Inc. (NYSE: EDR) Class A common stock between January 15, 2025 and March 24, 2025, both dates inclusive (the “Class Period”). Endeavour is a global sports and entertainment conglomerate.

For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653.

The Allegations: Rosen Law Firm is Investigating the Allegations that Endeavour Group Holdings, Inc. (NYSE: EDR) Misled Investors Regarding its Business Operations.

The lawsuit seeks to recover damages on behalf of investors that were damaged as a result of allegedly false and misleading statements and omissions of material facts in the January 15, 2025 Information Statement (filed with the U.S. Securities and Exchange Commission (the “SEC”) pursuant to the securities laws) and subsequent amendment issued by defendants, and related filings with the SEC. Among other things, the complaint alleges the Information Statement and other solicitation materials misled investors regarding the true value of Endeavor’s shares, failed to adequately disclose the earnings of Endeavor’s executives under the terms of the Merger (a take-private merger), and failed to disclose conflicts of interests with Endeavor’s special committee and financial advisor.

What Now: You may be eligible to participate in the class action against Endeavour Group Holdings, Inc. Former shareholders who want to serve as lead plaintiff for the class must file their motions with the court by March 18, 2026. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

About Rosen Law Firm: Some law firms issuing releases about this matter do not actually litigate securities class actions. Rosen Law Firm does. Rosen Law Firm is a recognized leader in shareholder rights litigation, dedicated to helping shareholders recover losses, improving corporate governance structures, and holding company executives accountable for their wrongdoing. Since its inception, Rosen Law Firm has obtained over $1 billion for shareholders.

Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contacts

Laurence Rosen, Esq.

Phillip Kim, Esq.

The Rosen Law Firm, P.A.

275 Madison Avenue, 40th Floor

New York, NY 10016

Tel: (212) 686-1060

Toll Free: (866) 767-3653

Fax: (212) 202-3827

case@rosenlegal.com
www.rosenlegal.com

Market Opportunity
WorldAssets Logo
WorldAssets Price(INC)
$0.6817
$0.6817$0.6817
+0.73%
USD
WorldAssets (INC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.